Skip to main content
Premium Trial:

Request an Annual Quote

President to Seek Earmark Cuts in Spending Bill that Funds NIH

NEW YORK (GenomeWeb News) – The US House of Representatives late yesterday passed an omnibus spending bill that would provide fiscal 2008 funding of $29.2 billion for the National Institutes of Health — $800 million less than Congress had initially sought.
 
The House sent the bill to the White House to be signed by President George W. Bush, but he will likely seek earmark cuts.
 
Though the president kept his veto pen holstered today, he said in an end-of-year press conference that he was “disappointed” with the amount of spending in the omnibus budget bill. The President said he would ask White House Budget Director Jim Nussle to review the bill for areas where the administration could propose cuts.
 
The $29.2 billion in funding for the NIH that the House and Senate passed this week may not be an area where Bush would look to cut, although it is around half a billion dollars more than he asked for in his budget proposal.
 
The House passed the bill last night with strong Republican support, while Democratic support of the bill had waned compared to an earlier draft. Overall, 194 Republicans voted in favor of this draft of the bill compared to only 78 Democrats. 
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.